Summary
Updated Aug 30, 2026
Andrew Moin files SEC Form 4 reports at SAB Biotherapeutics, Inc. (SABS). 2 SEC Form 4 filings on record, most recently on 29 September 2025.
Recent Transactions
1Every recent SEC Form 4 transaction Andrew Moin has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Andrew Moin's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Bain Capital Life Sciences Investors, LLC - $115.00M of HTFL open-market activity in the last 12 months
- Herriot Tabuteau - $110.58M of AXSM open-market activity in the last 12 months
- Mayukh Sukhatme - $109.13M of ROIV open-market activity in the last 12 months
- Michael Simanovsky - $105.88M of SNDA open-market activity in the last 12 months
- Eric Venker - $103.97M of ROIV open-market activity in the last 12 months
- Bruce Booth - $100.59M of KYMR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Andrew Moin?
Andrew Moin is a corporate insider of SAB Biotherapeutics, Inc. (SABS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Andrew Moin last file a Form 4?
The most recent primary Form 4 on record is dated 29 September 2025, one of 2 filings going back to 2025.
Where can I see all of Andrew Moin's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Andrew Moin and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
